Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 8c; Boosts FY15 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Leerink Partners Remains Bullish on Zimmer Biomet Holdings (ZBH) Following an In-Line 3Q
October 30, 2015 11:54 AM EDTLeerink Partners maintained an Outperform rating on Zimmer Holdings (NYSE: ZBH), and cut the price target to $125.00 (from $130.00), following the company's 3Q earnings results. 3Q revenues of $1.76B was in-line with consensus, along with of $1.64.
Analyst Richard Newitter commented, "Expectations were low, but ZBH's 3Q... More
